Chromosome 21 gain is dispensable for transient myeloproliferative disorder driven by a novel GATA1 mutation

Leukemia. 2020 Sep;34(9):2503-2508. doi: 10.1038/s41375-020-0769-1. Epub 2020 Feb 24.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromosomes, Human, Pair 12*
  • Down Syndrome / genetics*
  • GATA1 Transcription Factor
  • Humans
  • Janus Kinase 1 / genetics
  • Leukemoid Reaction / genetics*
  • Male
  • Mutation*

Substances

  • GATA1 Transcription Factor
  • GATA1 protein, human
  • JAK1 protein, human
  • Janus Kinase 1

Supplementary concepts

  • Myeloproliferative Syndrome, Transient